Intervacc AB (publ) (IVACC.ST)
Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden.
1.27-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+11.0%
The outlook
Intervacc AB (publ) currently reads as leaning bullish based on mixed vs its moving averages, 78% of the way from its 52-week low to high, avg target +61% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range78% of the way from its 52-week low to high
Price targetAvg target +61% vs current price
Analyst price target
~12-month · 2 analysts2.05average target+61.4% vs now
Now 1.27
Low 2.00High 2.10
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$432.8M
52-wk high
1.46
52-wk low
0.57
50-day avg
1.27
200-day avg
1.01
Trailing P/E
—